Search Results 131-140 of 17104 for pharmacogenetics
About this study. The overall goals of this pilot study are to: (1) describe pharmacogenomics (PGx) testing results and identify PGx variants that may ...
The center has established service lines in cancer, rare and undiagnosed diseases, pharmacogenomics, and predictive genomics and is integrating these services ...
Pharmacogenetics of cardiovascular drugs. Curr Opin Cardiol. 2023 May 1; 38 ... Epub 2022 Dec 06. View PubMed; Castrichini M, Luzum JA, Pereira N.
Pharmacogenetic testing (such as cytochrome P450 2D6 and 2C19, serotonin transporter gene); Transcranial magnetic stimulation; Psychotherapy techniques (such ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...
THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer ...
Overview Tab Title Description Study type Observational Study IDs Study type Observational Describes the nature of a clinical study.
About this study. This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of ...
Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!